Daniel W. McKeel

21.9k total citations · 7 hit papers
82 papers, 16.5k citations indexed

About

Daniel W. McKeel is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Daniel W. McKeel has authored 82 papers receiving a total of 16.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Physiology, 32 papers in Psychiatry and Mental health and 20 papers in Molecular Biology. Recurrent topics in Daniel W. McKeel's work include Alzheimer's disease research and treatments (34 papers), Dementia and Cognitive Impairment Research (32 papers) and Growth Hormone and Insulin-like Growth Factors (8 papers). Daniel W. McKeel is often cited by papers focused on Alzheimer's disease research and treatments (34 papers), Dementia and Cognitive Impairment Research (32 papers) and Growth Hormone and Insulin-like Growth Factors (8 papers). Daniel W. McKeel collaborates with scholars based in United States, Belarus and Japan. Daniel W. McKeel's co-authors include John C. Morris, Joseph L. Price, L Berg, Suzanne S. Mirra, J. Philip Miller, Eugene H. Rubin, Gerald van Belle, Barbara J. Crain, John P. Hughes and F. Stephen Vogel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Genes & Development.

In The Last Decade

Daniel W. McKeel

82 papers receiving 16.0k citations

Hit Papers

The Consortium to Establish a Registry for Alzheimer's... 1970 2026 1988 2007 1991 2001 1996 2000 2001 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
    1991 4.0k citations Suzanne S. Mirra, Daniel W. McKeel et al. Neurology profile →
  2. Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
    2001 1.5k citations Julie Morris, Martha Storandt et al. Archives of Neurology profile →
  3. Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
    1996 1.4k citations Joseph L. Price, Daniel W. McKeel et al. profile →
  4. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
    2000 726 citations David M. Holtzman, Kelly R. Bales et al. profile →
  5. Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease
    2001 561 citations Daniel W. McKeel, John C. Morris et al. Neurology profile →
  6. Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease
    1998 546 citations Daniel W. McKeel, J. Philip Miller et al. Archives of Neurology profile →
  7. PREPARATION AND CHARACTERIZATION OF A PLASMA MEMBRANE FRACTION FROM ISOLATED FAT CELLS
    1970 362 citations Daniel W. McKeel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel W. McKeel United States 45 9.9k 6.1k 4.4k 2.9k 2.4k 82 16.5k
Suzanne S. Mirra United States 45 10.3k 1.0× 5.3k 0.9× 4.4k 1.0× 3.2k 1.1× 1.4k 0.6× 101 16.4k
Lennart Minthon Sweden 76 11.1k 1.1× 8.3k 1.4× 4.2k 0.9× 3.8k 1.3× 2.1k 0.9× 264 18.9k
André Delacourte France 66 10.7k 1.1× 3.4k 0.6× 7.1k 1.6× 3.2k 1.1× 1.5k 0.6× 201 18.1k
Teresa Gómez‐Isla United States 55 8.5k 0.9× 3.5k 0.6× 3.6k 0.8× 2.8k 1.0× 1.9k 0.8× 116 13.7k
Elaine R. Peskind United States 87 7.9k 0.8× 5.6k 0.9× 4.8k 1.1× 2.8k 1.0× 2.7k 1.1× 294 23.0k
Simon Lovestone United Kingdom 79 9.5k 1.0× 5.3k 0.9× 7.7k 1.7× 2.7k 0.9× 1.9k 0.8× 368 21.0k
Barbara J. Crain United States 54 8.0k 0.8× 4.9k 0.8× 5.2k 1.2× 2.7k 0.9× 2.3k 0.9× 153 20.0k
Leon J. Thal United States 69 8.8k 0.9× 8.9k 1.5× 4.3k 1.0× 3.4k 1.2× 4.5k 1.9× 204 25.4k
Stanley I. Rapoport United States 80 5.7k 0.6× 4.0k 0.7× 6.9k 1.5× 2.6k 0.9× 3.0k 1.3× 487 22.7k
Hugo Vanderstichele Belgium 57 10.8k 1.1× 6.6k 1.1× 4.6k 1.0× 2.5k 0.9× 1.3k 0.5× 156 14.8k

Countries citing papers authored by Daniel W. McKeel

Since Specialization
Citations

This map shows the geographic impact of Daniel W. McKeel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. McKeel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. McKeel more than expected).

Fields of papers citing papers by Daniel W. McKeel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel W. McKeel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. McKeel. The network helps show where Daniel W. McKeel may publish in the future.

Co-authorship network of co-authors of Daniel W. McKeel

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel W. McKeel. A scholar is included among the top collaborators of Daniel W. McKeel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel W. McKeel. Daniel W. McKeel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghoshal, Nupur, Arie Perry, Daniel W. McKeel, et al.. (2014). Variably Protease-sensitive Prionopathy in an Apparent Cognitively Normal 93-Year-Old. Alzheimer Disease & Associated Disorders. 29(2). 173–176. 6 indexed citations
2.
Nunomura, Akihiko, Nobutaka Motohashi, Masao Nakamura, et al.. (2012). The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons. Journal of Neuropathology & Experimental Neurology. 71(3). 233–241. 98 indexed citations
3.
Liang, Winnie S., Travis Dunckley, Thomas G. Beach, et al.. (2008). Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology. Neurobiology of Aging. 31(4). 549–566. 63 indexed citations
4.
Dunckley, Travis, Thomas G. Beach, Keri E. Ramsey, et al.. (2005). Gene expression correlates of neurofibrillary tangles in Alzheimer's disease. Neurobiology of Aging. 27(10). 1359–1371. 142 indexed citations
5.
Snider, B. Joy, Joanne Norton, Mary A. Coats, et al.. (2005). Novel Presenilin 1 Mutation (S170F) Causing Alzheimer Disease With Lewy Bodies in the Third Decade of Life. Archives of Neurology. 62(12). 1821–1821. 96 indexed citations
6.
Zanjani, Hadi, Caleb E. Finch, Claudia Kemper, et al.. (2005). Complement Activation in Very Early Alzheimer Disease. Alzheimer Disease & Associated Disorders. 19(2). 55–66. 94 indexed citations
7.
Clark, Christopher M., Sharon X. Xie, Jesse Chittams, et al.. (2003). Cerebrospinal Fluid Tau and β-Amyloid. Archives of Neurology. 60(12). 1696–1696. 294 indexed citations
8.
Zhukareva, Victoria, David M. A. Mann, Magnus Sjögren, et al.. (2003). Selective reduction of soluble Tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. Acta Neuropathologica. 105(5). 469–476. 43 indexed citations
9.
Brendza, Robert P., Kelly Simmons, Daniel W. McKeel, et al.. (2003). PDAPP; YFP double transgenic mice: A tool to study amyloid‐β associated changes in axonal, dendritic, and synaptic structures. The Journal of Comparative Neurology. 456(4). 375–383. 52 indexed citations
10.
Han, Xianlin, et al.. (2002). Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. Journal of Neurochemistry. 82(4). 809–818. 495 indexed citations
11.
Csernansky, John G., J. Philip Miller, Daniel W. McKeel, & John C. Morris. (2002). Relationships Among Cerebrospinal Fluid Biomarkers in Dementia of the Alzheimer Type. Alzheimer Disease & Associated Disorders. 16(3). 144–149. 33 indexed citations
12.
Price, Joseph L., et al.. (2001). Neuron Number in the Entorhinal Cortex and CA1 in Preclinical Alzheimer Disease. Archives of Neurology. 58(9). 1395–1395. 462 indexed citations
13.
Morris, Julie, Martha Storandt, J. Philip Miller, et al.. (2001). Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease. Archives of Neurology. 58(3). 397–405. 1468 indexed citations breakdown →
14.
Farber, Nuri B., Eugene H. Rubin, John W. Newcomer, et al.. (2000). Increased Neocortical Neurofibrillary Tangle Density in Subjects With Alzheimer Disease and Psychosis. Archives of General Psychiatry. 57(12). 1165–1165. 130 indexed citations
15.
McKeel, Daniel W., J. Philip Miller, Martha Storandt, et al.. (1998). Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease. Archives of Neurology. 55(3). 326–326. 546 indexed citations breakdown →
16.
Morris, John C., Martha Storandt, Daniel W. McKeel, et al.. (1996). Cerebral amyloid deposition and diffuse plaques in ``normal'' aging. Neurology. 46(3). 707–719. 448 indexed citations
17.
Bartlett, Thad Q., et al.. (1994). Interactive segmentation of cerebral gray matter, white matter, and CSF: Photographic and MR images. Computerized Medical Imaging and Graphics. 18(6). 449–460. 13 indexed citations
18.
Hibbard, Lyndon S., et al.. (1994). Computed detection and quantitative morphometry of Alzheimer senile plaques. Journal of Neuroscience Methods. 52(2). 175–189. 6 indexed citations
19.
Kovalic, Jeffrey J., Gwen Mazoujian, Daniel W. McKeel, Barbara Fineberg, & Perry W. Grigsby. (1993). Immunohistochemistry as a predictor of clinical outcome in patients given postoperative radiation for subtotally resected pituitary adenomas. Journal of Neuro-Oncology. 16(3). 227–232. 4 indexed citations
20.
McKeel, Daniel W., Melvyn J. Ball, Joseph L. Price, et al.. (1993). Interlaboratory Histopathologic Assessment of Alzheimer Neuropathology. Alzheimer Disease & Associated Disorders. 7(3). 136–151. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suzanne S. Mirra Breakdown of academic impact, for papers by Lennart Minthon Breakdown of academic impact, for papers by André Delacourte Breakdown of academic impact, for papers by Teresa Gómez‐Isla Breakdown of academic impact, for papers by Elaine R. Peskind Breakdown of academic impact, for papers by Simon Lovestone Breakdown of academic impact, for papers by Barbara J. Crain Breakdown of academic impact, for papers by Leon J. Thal Breakdown of academic impact, for papers by Stanley I. Rapoport Breakdown of academic impact, for papers by Hugo Vanderstichele
Rankless by CCL
2026